IRCT20090117001556N133尚未招募2 期
Theanine as an adjuvant therapy added to Risperidone for the treatment of patients with chronic schizophrenia: A randomized double blind and placebo controlled clinical trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •Diagnosis of schizophrenia based on DSM-5.
- •Minimum score of 60 based on PANSS.
- •Age range: 18-55 years.
- •At least, 2 years have passed since the onset of the disorder.
排除标准
- •Diagnosis of another disorder in axis II.
- •Existence of a significant neurological or organic disease.
- •IQ less than 70 based on interviewer clinical suspicion.
- •Substance/drug dependence during the last 6 months (except nicotine and caffeine).
- •Use of antipsychotics during past 1 week or long-term antipsychotics during past 1 month.
- •Receiving ECT during the last 2 weeks.
- •Abnormal endocrine activity.
- •Abnormal kidney and liver function.
- •History of trombosis and embolia.
- •History of abnormal bleeding.
研究者
相似试验
尚未招募
2 期
Theanine as an adjuvant therapy in the treatment of major depressive disorderMajor Depressive Disorder.Major depressive disorder, single episode, severe without psychotic featuresF32.2IRCT20090117001556N131Tehran University of Medical Sciences50
已完成
不适用
Carnosine in the treatment of AutismAutistic Disorder.Childhood autismIRCT201512081556N83Tehran University of Medical Sciences50
尚未招募
2 期
Fingolimod in the treatment of schizophreniaSchizophreniaIRCT20090117001556N137Tehran University of Medical Sciences50
招募中
2 期
Amantadin as adjuvant therapy in the treatment of moderate to severe OCDObsessive-compulsive disorderObsessive- Cumpulsive Disorder.IRCT201705191556N99Tehran University of Medical Sciences50
已完成
2 期
Riluzole in the treatment of autismChildhood autism.Childhood autismIRCT201107281556N27Tehran University of Medical Sciences40